Insulin resistance in non-diabetic premenopausal female patients with fibromyalgia: relation to disease characteristics
摘要
Fibromyalgia syndrome (FMS) and insulin resistance (IR) may share common pathophysiological features. We aimed to investigate the role of IR among FMS patients and investigate its relation to various mutations in the catechol-O-methyltransferase (COMT) gene.
Methods and resultsA case–control study which included 120 women (60 diagnosed as having FMS and 60 healthy women as a control group) aged from 22 to 40 years was conducted. Patients had significantly increased HbA1C% (5.49 ± 0.35) and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (1.74 ± 1.23) than controls (4.99 ± 0.27 and 0.92 ± 0.15, respectively) (p < 0.001). The patients with the COMT A/A genotype had significantly higher mean values of the symptom severity score, painDETECT, McGill Pain, visual analog scale, Fibromyalgia Impact Questionnaire, and Small Fiber Neuropathy Screening List (p = 0.004, 0.004, 0.013, 0.019, 0.005, and 0.001, respectively).
ConclusionIR was significantly higher among FMS patients, and patients with the COMT A/A allele had greater pain sensitivity. Thus, IR may have an add-on effect on pain in FM.